Rchr
J-GLOBAL ID:201501083513267892   Update date: Apr. 11, 2024

Matsumoto Junya

マツモト ジュンヤ | Matsumoto Junya
Affiliation and department:
Job title: Section Chief
Homepage URL  (1): https://www.researchgate.net/profile/Junya_Matsumoto
Research field  (8): Psychiatry ,  Neuroanatomy and physiology ,  Neuroscience - general ,  Basic brain sciences ,  Cognitive neuroscience ,  Physical anthropology ,  Cognitive sciences ,  Clinical psychology
Research keywords  (13): Biological Psychiatry ,  Neuroimaging ,  Cognitive decline/Cognitive impairment/Cognitive discrepancy ,  Disaster Psychiatry ,  Schizophrenia ,  Mood disorder ,  Social function ,  Neurodevelopmental Disorder ,  Attention-deficit hyperactivity disorder ,  Dissemination of guidelines to psychiatrists, post-graduate education, and medical education ,  Liaison Psychiatry ,  Brain Bank ,  Postmortem Brain
Research theme for competitive and other funds  (11):
  • 2023 - 2026 A large multicenter cross-disorder study of premorbid estimated intelligence and brain structural imaging in psychiatric disorders.
  • 2021 - 2026 Schizophrenia Diagnostic Medical Device Program
  • 2022 - 2025 Validation study on social implementation of psychiatric guidelines
  • 2021 - 2025 Interactive translational research across psychiatric disorders by integrating iPS cell technology and data science
  • 2020 - 2023 Development of a new diagnostic system based on brain pathophysiology of psychiatric disorders using multidimensional neuroimaging and genomics
Show all
Papers (88):
  • Shuntaro Itagaki, Takashi Ohnishi, Wataru Toda, Aya Sato, Junya Matsumoto, Hiroshi Ito, Shiro Ishii, Ryo Yamakuni, Itaru Miura, Hirooki Yabe. Reduced dopamine transporter availability in drug-naive adult attention-deficit/hyperactivity disorder. Psychiatry and Clinical Neurosciences Reports. 2024. 3. 1
  • Ryuichi Yamazaki, Junya Matsumoto, Satsuki Ito, Kiyotaka Nemoto, Masaki Fukunaga, Naoki Hashimoto, Fumitoshi Kodaka, Harumasa Takano, Naomi Hasegawa, Yuka Yasuda, et al. Longitudinal reduction in brain volume in patients with schizophrenia and its association with cognitive function. Neuropsychopharmacology reports. 2024
  • Yamagata H, Fujii Y, Ochi S, Seki T, Hasegawa N, Yamada H, Hori H, Ichihashi K, Iga J, Ogasawara K, et al. Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for Dissemination and education in psychiatric treatment (EGUIDE) project. Psychiatry Research Communications. 2024. 4. 100158
  • Mizuki Hino, Yasuto Kunii, Risa Shishido, Atsuko Nagaoka, Junya Matsumoto, Hiroyasu Akatsu, Yoshio Hashizume, Hideki Hayashi, Akiyoshi Kakita, Hiroaki Tomita, et al. Marked alteration of phosphoinositide signaling-associated molecules in postmortem prefrontal cortex with bipolar disorder. Neuropsychopharmacology Reports. 2024
  • Ito S, Ohi K, Yasuda Y, Fujimoto M, Yamamori H, Matsumoto J, Fukumoto K, Kodaka F, Hasegawa N, Ishimaru K, et al. Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia. Schizophrenia (Heidelb). 2023. 9. 1. 78-78
more...
MISC (166):
  • 松本純弥, 三浦健一郎, 根本清貴方, 安田由華, 橋本亮太. 精神疾患における画像診断の最前線-現状と今後の可能性-. 月刊インナービジョン 特集「NeuroradiologyFrontier 2024中枢神経の画像診断最前線-最先端技術で広がる臨床の可能性-」. 2024. 39. 1. 56-59
  • 伊藤 颯姫, 大井 一高, 安田 由華, 藤本 美智子, 山森 英長, 松本 純弥, 福本 健太郎, 小高 文聰, 長谷川 尚美, 石丸 径一郎, et al. 統合失調症患者における薬物治療ガイドライン適合度と労働時間の関係. 日本神経精神薬理学会年会プログラム・抄録集. 2023. 53回. 149-149
  • 松本 純弥, 福永 雅喜, 三浦 健一郎, 岡田 直大, 根本 清貴, 藤本 美智子, 肥田 道彦, 宮田 淳, 大井 一高, 中瀧 理仁, et al. 多施設共同研究による統合失調症と双極性障害の大脳皮質構造画像解析. 精神神経学雑誌. 2023. 2023特別号. S398-S398
  • 山﨑龍一, 三浦健一郎, 松本純弥, 橋本亮太. 脳神経画像の解析と縦断データに基づく,精神疾患の治療効果および予後に関する層別化、特集1/精神疾患レジストリによって何がわかるか?. 月刊精神科. 2023. 42. 6. 738-744
  • 三浦健一郎, 松本純弥, 長谷川尚美, 橋本亮太. 画像・生理学的指標による統合失調症診断の可能性. 臨床精神医学. 2023. 52. 5. 475-481
more...
Books (1):
  • 統合失調症治療の新たなストラテジー
    先端医学社 2021 ISBN:9784865505030
Lectures and oral presentations  (230):
  • 視覚サリエンス処理の精神疾患間の比較
    (第45回日本生物学的精神医学会年会 2023)
  • 統合失調症とうつ病における治療ガイドラインと大規模多施設研究によるreal-world study
    (第45回日本生物学的精神医学会年会 2023)
  • 児童思春期発症のうつ病の多施設大規模データによる大脳皮質構造解
    (第45回日本生物学的精神医学会年会 2023)
  • 多施設共同研究によるdrug freeの統合失調症患者における大脳皮質構造への疾患の効果の検討
    (第45回日本生物学的精神医学会年会 2023)
  • 統合失調症における側性化の変化:VBMによる大規模比較研究
    (2023)
more...
Education (2):
  • 2009 - 2012 Fukushima Medical University, Graduate School of Medicine Department of Medical Science
  • 2001 - 2007 Fukushima Medical University School of Medicine, Faculty of Medicine
Professional career (2):
  • M.D. (Fukushima Medical University)
  • Ph.D. (Fukushima Medical University)
Work history (12):
  • 2019/04 - 現在 Osaka University United Graduate School of Child Development, Osaka University, Kanazawa University,Hamamatsu University School of Medicine,Chiba University and University of Fukui Guest teacher
  • 2019/04 - 現在 National Institute of Mental Health, National Center of Neurology and Psychiatry Department of Pathology of Mendtal Diseases Section Chief
  • 2018/08 - 2019/03 Fukushima Medical University School of Medicine Department of Neuropsychiatry Senior Lecturer
  • 2017/04 - 2019/03 Fukushima Prefectural General Hygiene Institute Part-time lecturers
  • 2017/04 - 2018/07 Fukushima Medical University School of Medicine Department of Neuropsychiatry Assistant Professor
Show all
Committee career (4):
  • 2021/07 - 現在 Japanese Society of Biological Psychiatry Trustee
  • 2018/08 - 2019/03 Fukushima Prefecture Dementia Policy Promotion Council Early-onset dementia policy implementation and advancement ministry members
  • 2018/07 - 2019/03 Fukushima Psychological Care Center Advisor
  • 2010/04 - 2019/03 Postmortem Brain and DNA Bank of Fukushima for Psychiatric Research Steering Committee
Awards (11):
  • 2022/11 - The 44th Annual Meeting of the Japanese Society of Biological Psychiatry, the 32nd Annual Meeting of the Japanese Society of Clinical Neuropsychopharmacology, the 52nd Annual Meeting of the Japanese Society of Neuropsychopharmacology, and the 6th Annual Meeting and Congress of the Japanese Society of Psychopharmacology (BPCNPPP Joint Annual Meeting of the Four Societies) Best Presentation Award
  • 2022/03 - The 16th Annual Meeting of the Japanese Society of Schizophrenia Research The Best Presentation Award
  • 2022/03 - The Japanese Society of Schizophrenia Research The 2nd Incentive Award for Presentations of Young Scientists at International Academic Conferences
  • 2021/12 - The Japanese Society of Neuropsychopharmacology JSNP Excellent Presentation Award for AsCNP2021
  • 2020/09 - The Japanese Society of Psychiatry and Neurology Best Presentation Award at the 116th Annual Meeting of the Japanese Society of Psychiatry and Neurology Association between myelination of axons in cerebral white matter, maturation of cerebral white matter, and working hours as a measure of cognitive and social function
Show all
Association Membership(s) (18):
Schizophrenia International Research Society ,  Japanese Society of Mood Disorders ,  The International College of Neuropsychopharmacology ,  Asian College of Neuropsychopharmacology ,  The Japanese Society of Clinical Neuropsychopharmacology ,  The Japanese Society of Neuropsychopharmacology ,  Japanese Psychogeriatric Society ,  The Japanese Society for Child and Adolescent Psychiatry ,  Japanese Society of General Hospital Psychiatry ,  Utena’s Brief Objective Measures research society ,  Japanese Society of Schizoophreni Research ,  Japanese Society of Biological Psychiatry ,  World Federation of Biological Psychiatry ,  The Japanese Society of Psychiatry and Neurology ,  The Tohoku Society of Psychiatry and Neurology ,  Fukushima Psychiatric Society ,  European College of Neuropsychopharmacology ,  Society for Neuroscience
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page